APA

Hesse L., Brouwer U., Petersen A. H., Gras R., Bosman L., Brimnes J., Oude Elberink J. N. G., van Oosterhout A. J. M. & Nawijn M. C. (20191114). Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Chicago

Hesse L, Brouwer U, Petersen A H, Gras R, Bosman L, Brimnes J, Oude Elberink J N G, van Oosterhout A J M and Nawijn M C. 20191114. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Harvard

Hesse L., Brouwer U., Petersen A. H., Gras R., Bosman L., Brimnes J., Oude Elberink J. N. G., van Oosterhout A. J. M. and Nawijn M. C. (20191114). Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

MLA

Hesse L, Brouwer U, Petersen A H, Gras R, Bosman L, Brimnes J, Oude Elberink J N G, van Oosterhout A J M and Nawijn M C. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 20191114.